Literature DB >> 9920099

Free leptin, bound leptin, and soluble leptin receptor in normal and diabetic pregnancies.

K Lewandowski1, R Horn, C J O'Callaghan, D Dunlop, G F Medley, P O'Hare, G Brabant.   

Abstract

We measured serum levels of free leptin, bound leptin, and soluble leptin receptor by specific RIA methods in 20 normal and 19 insulin-dependent diabetes mellitus subjects at 20 and 30 weeks gestation and postpartum, and analyzed the data using hierarchical statistical models. Total leptin levels rise from 20-30 weeks gestation (688 +/- 58 to 785 +/- 62 pmol/L, mean +/- SEM; P = 0.009). There is a significant postpartum fall to 445 +/- 47 pmol/L (P < 0.001). This rise is caused by the rise in the bound leptin levels, as there is no significant change in free leptin levels between 20 and 30 weeks (P = 0.17). There is a significant postpartum fall in free leptin levels (P < 0.001). Insulin requirements rise in the third trimester, but despite this there was no significant difference in free or bound leptin levels between the normal and diabetic subjects at any stage [free leptin, 223 +/- 35 and 266 +/- 24, 237 +/- 45 and 223 +/- 27, and 109 +/- 16 and 104 +/- 24 (P = 0.34); bound leptin, 410 +/- 73 and 428 +/- 54, 501 +/- 78 and 562 +/- 71, and 330 +/- 47 and 271 +/- 46 (P = 0.84); for normals and diabetics at 20 and 30 weeks gestation and postpartum, respectively]. Diabetic subjects, however, had significantly higher soluble leptin receptor levels at all stages (P << 0.001), which rose further in the third trimester from 3742 +/- 268 (mean +/- SEM) to 4134 +/- 239 pmol/L, whereas in the normal group there was a fall from 3149 +/- 169 to 2712 +/- 123 (P = 0.05). There is a linear relationship between the soluble leptin receptor levels and the body mass index in the diabetic group only. We conclude that there is no significant difference in free or bound leptin levels between the normal and insulin-dependent diabetic subjects either during pregnancy or postpartum, but female insulin-dependent diabetic subjects have significantly higher soluble leptin receptor levels. We speculate that high soluble leptin receptor levels might be implicated in the development of the leptin resistance in this group.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920099     DOI: 10.1210/jcem.84.1.5401

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

1.  Postnatal changes in concentrations of free and bound leptin.

Authors:  T K Hytinantti; M Juntunen; H A Koistinen; V A Koivisto; S L Karonen; S Andersson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

Review 2.  Determinants of early life leptin levels and later life degenerative outcomes.

Authors:  Delia-Marina Alexe; Garyfallia Syridou; Eleni Th Petridou
Journal:  Clin Med Res       Date:  2006-12

3.  Longitudinal changes in adipokines and free leptin index during and after pregnancy in women with obesity.

Authors:  Ulrika Andersson-Hall; Pernilla Svedin; Henrik Svensson; Malin Lönn; Carina Mallard; Agneta Holmäng
Journal:  Int J Obes (Lond)       Date:  2019-09-24       Impact factor: 5.095

Review 4.  Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: A systematic review.

Authors:  Wei Bao; Aileen Baecker; Yiqing Song; Michele Kiely; Simin Liu; Cuilin Zhang
Journal:  Metabolism       Date:  2015-01-29       Impact factor: 8.694

Review 5.  Molecular cues on obesity signals, tumor markers and endometrial cancer.

Authors:  Danielle Daley-Brown; Gabriela M Oprea-Ilies; Regina Lee; Roland Pattillo; Ruben R Gonzalez-Perez
Journal:  Horm Mol Biol Clin Investig       Date:  2015-01

6.  Hyperleptinemia in pregnant bats is characterized by increased placental leptin secretion in vitro.

Authors:  N Kronfeld-Schor; J Zhao; B A Silvia; P T Mathews; S Zimmerman; E P Widmaier; T H Kunz
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

7.  Leptin receptor (LEPR) SNP polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analysis.

Authors:  Tibor Várkonyi; Levente Lázár; Attila Molvarec; Nándor Gábor Than; János Rigó; Bálint Nagy
Journal:  BMC Med Genet       Date:  2010-02-11       Impact factor: 2.103

8.  Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease.

Authors:  Xiao-Dong Huang; Yan Fan; Hen Zhang; Ping Wang; Jing-Ping Yuan; Ming-Jie Li; Xi-Yan Zhan
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

Review 9.  Leptin-cytokine crosstalk in breast cancer.

Authors:  Gale Newman; Ruben Rene Gonzalez-Perez
Journal:  Mol Cell Endocrinol       Date:  2013-04-04       Impact factor: 4.102

10.  Cerebrospinal fluid levels of leptin, proopiomelanocortin, and agouti-related protein in human pregnancy: evidence for leptin resistance.

Authors:  Gabrielle Page-Wilson; Elena Reitman-Ivashkov; Kana Meece; Anne White; Michael Rosenbaum; Richard M Smiley; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2012-11-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.